ArticleJournal of pharmaceutical analysis2024

Antibody-platinum (IV) prodrugs conjugates for targeted treatment of cutaneous squamous cell carcinoma.

Xiangye Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.